Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of AVITA Medical Inc (NASDAQ: RCEL) closed at $5.42 in the last session, up 4.84% from day before closing price of $5.17. In other words, the price has increased by $4.84 from its previous closing price. On the day, 0.21 million shares were traded. RCEL stock price reached its highest trading level at $5.53 during the session, while it also had its lowest trading level at $5.31.
Ratios:
We take a closer look at RCEL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.72 and its Current Ratio is at 2.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on December 24, 2024, initiated with a Buy rating and assigned the stock a target price of $25.
On June 27, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $23.Cantor Fitzgerald initiated its Overweight rating on June 27, 2023, with a $23 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when McNamara Robert bought 11,000 shares for $8.30 per share. The transaction valued at 91,300 led to the insider holds 56,749 shares of the business.
McNamara Robert bought 10,000 shares of RCEL for $100,900 on Feb 20 ’25. The Director now owns 45,749 shares after completing the transaction at $10.09 per share. On Feb 20 ’25, another insider, O’Toole David D, who serves as the CFO of the company, bought 1,000 shares for $9.90 each. As a result, the insider paid 9,900 and bolstered with 25,734 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCEL now has a Market Capitalization of 143276080 and an Enterprise Value of 158094336. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.88. Its current Enterprise Value per Revenue stands at 2.206 whereas that against EBITDA is -3.176.
Stock Price History:
The Beta on a monthly basis for RCEL is 1.63, which has changed by -0.3283767 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, RCEL has reached a high of $14.16, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is -20.14%, while the 200-Day Moving Average is calculated to be -42.90%.
Shares Statistics:
According to the various share statistics, RCEL traded on average about 288.74K shares per day over the past 3-months and 359230 shares per day over the past 10 days. A total of 26.43M shares are outstanding, with a floating share count of 24.55M. Insiders hold about 1.18% of the company’s shares, while institutions hold 28.51% stake in the company. Shares short for RCEL as of 1749772800 were 4486349 with a Short Ratio of 15.54, compared to 1747267200 on 3677068. Therefore, it implies a Short% of Shares Outstanding of 4486349 and a Short% of Float of 17.1.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
